Intra-Cellular Therapies, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
ITCI on Nasdaq
Industry
Pharmaceutical Preparations
Location
135 Route 202/206, Suite 6, Bedminster, NJ

Insiders trading volume in the past year

Intra-Cellular Therapies, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Christopher D. Alafi Director $377M May 27, 2021
Richard A. Lerner Director $7.16M Sep 30, 2021
Lawrence J. Hineline SVP of Finance, CFO $372K Mar 7, 2024
Joel S. Marcus Director $0 Apr 2, 2025
Sharon Mates Chairman and CEO, Director $0 -$8.72M -100% Apr 2, 2025
Eduardo Rene Salas Director $0 Apr 2, 2025
Michael Halstead President $0 Apr 2, 2025
Mark Neumann EVP, Chief Commercial Officer $0 Apr 2, 2025
Rory B. Riggs Director $0 Apr 2, 2025
Robert L. Van Nostrand Director $0 Apr 2, 2025
Suresh K. Durgam EVP, Chief Medical Officer $0 Apr 2, 2025
Sanjeev Narula Executive Vice President & CFO $0 Apr 2, 2025
Michael Rawlins Director Jun 9, 2022

Recent Insider Transactions by Companies or Individuals for Intra-Cellular Therapies, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.